(Q44416876)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Bram de Wilde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Koenraad K Norga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Simona Coco

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rogier Versteeg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jo Vandesompele

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

14

Frank Speleman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Tom Van Maerken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Fjoralba Zeka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Geneviève Laureys

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Gian Paolo Tonini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rosa Noguera

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Johannes H Schulte

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Angelika Eggert

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Raymond L Stallings

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

4 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1867-1870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

The p53 pathway and its inactivation in neuroblastoma.

4 March 2020

cites work

1 reference

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.

21 January 2018

1 reference

MDM2, MDMX and p53 in oncogenesis and cancer therapy

21 January 2018

1 reference

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients

21 January 2018

1 reference

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

21 January 2018

1 reference

MDM2 SNP309 accelerates colorectal tumour formation in women.

21 January 2018

1 reference

MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma

21 January 2018

1 reference

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.

21 January 2018

1 reference

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

21 January 2018

1 reference

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

21 January 2018

1 reference

Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.

21 January 2018

1 reference

Recent advances in neuroblastoma

21 January 2018

1 reference

The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24391119%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference